Cyclic RGD-Functionalized pH/ROS Dual-Responsive Nanoparticle for Targeted Breast Cancer Therapy
Breast cancer is the most common malignant tumor in women and is a big challenge to clinical treatment due to the high morbidity and mortality. The pH/ROS dual-responsive nanoplatforms may be an effective way to significantly improve the therapeutic efficacy of breast cancer. Herein, we report a doc...
Saved in:
Main Authors: | Pu Yao (Author), Xiaowen Wang (Author), Qianmei Wang (Author), Qing Dai (Author), Yu Peng (Author), Qian Yuan (Author), Nan Mou (Author), Shan Lv (Author), Bangbi Weng (Author), Yu Wang (Author), Fengjun Sun (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Folic acid-modified ROS-responsive nanoparticles encapsulating luteolin for targeted breast cancer treatment
by: Yu Wang, et al.
Published: (2021) -
Optimization of a siRNA Carrier Modified with a pH-Sensitive Cationic Lipid and a Cyclic RGD Peptide for Efficiently Targeting Tumor Endothelial Cells
by: Tomoya Hada, et al.
Published: (2015) -
Locally Injectable Chitosan/β-Glycerophosphate Hydrogel Doped with Triptolide-Human Serum Albumin Nanoparticles for Treating Rheumatoid Arthritis
by: Pu Yao, et al.
Published: (2024) -
ROS-Responsive and pH-Sensitive Aminothiols Dual-Prodrug for Radiation Enteritis
by: Yuanfang Chen, et al.
Published: (2022) -
A novel dendrimer-based complex co-modified with cyclic RGD hexapeptide and penetratin for noninvasive targeting and penetration of the ocular posterior segment
by: Xiucheng Yang, et al.
Published: (2019)